SCHEMBL29433417

SCHEMBL29433417

O=C(O)c1ccccc1OCc1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SGMS2 Q8NHU3 3/20 0.66
FOLH1 Q04609 1/20 0.64
PTGER1 P34995 1/20 0.63
ALDH1A1 P00352 5/20 0.63
KMT2A Q03164 1/20 0.62
PTK2B Q14289 1/20 0.62
HTT P42858 2/20 0.62
NPC1 O15118 1/20 0.62
KDM4E B2RXH2 2/20 0.61
GAA P10253 1/20 0.60
PARP1 P09874 1/20 0.58
L3MBTL1 Q9Y468 2/20 0.57
MCL1 Q07820 1/20 0.57
LMNA P02545 1/20 0.57
MAPT P10636 1/20 0.57
POLB P06746 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL112903 1.00 SGMS2 (0.66) SGMS2FOLH1PTGER1ALDH1A1KMT2A
SCHEMBL17799483 0.98 SGMS2 (0.64) SGMS2FOLH1PTGER1ALDH1A1KMT2A
Bicarbonate SCHEMBL236872 0.98 SGMS2 (0.64) SGMS2FOLH1PTGER1ALDH1A1KMT2A
Bicarbonate SCHEMBL29914194 0.98 SGMS2 (0.64) SGMS2FOLH1PTGER1ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL8998291 0.98 SGMS2 (0.64) SGMS2FOLH1PTGER1ALDH1A1KMT2A
Bicarbonate SCHEMBL21753662 0.98 SGMS2 (0.64) SGMS2FOLH1PTGER1ALDH1A1KMT2A
Ethyne SCHEMBL29820055 0.96 SGMS2 (0.62) SGMS2FOLH1PTGER1ALDH1A1KMT2A
SCHEMBL5839516 0.92 NR4A1 (0.63) SGMS2FOLH1PTGER1ALDH1A1PARP1
SCHEMBL27610143 0.91 GAA (0.64) SGMS2FOLH1PTGER1ALDH1A1KMT2A
SCHEMBL11153592 0.90 KDM4E (0.62) SGMS2FOLH1PTGER1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3784707-B1 STABLE POLYUREA MICROCAPSULE COMPOSITIONS INT FLAVORS & FRAGRANCES INC (US) 2025-12-24 EP claimed
US-20250283018-A1 TOILET RIM BLOCKS WITH SCENT CHANGE SYMRISE AG (DE) 2025-09-11 US claimed
EP-4045490-B1 NEW AROMATIC MONOTHIOKETALS AS FRAGRANCES SYMRISE AG (DE) 2025-12-03 EP disclosed
EP-4615837-A1 USEFUL COMPOUNDS FOR MODULATING INFLAMMATION Flagship Pioneering Innovations VI, LLC (US) 2025-09-17 EP disclosed
US-20250283018-A1 TOILET RIM BLOCKS WITH SCENT CHANGE SYMRISE AG (DE) 2025-09-11 US disclosed
US-20250170074-A1 PRECURSORS FOR THE CONTROLLED RELEASE OF A,B-UNSATURATED ALDEHYDES OR KETONES AND OTHER HIGH IMPACT FRAGRANCE SUBSTANCES SYMRISE AG (DE) 2025-05-29 US disclosed
EP-4373805-B1 PRECURSORS FOR THE CONTROLLED RELEASE OF ALPHA, BETA-UNSATURATED ALDEHYDES OR KETONES AND OTHER HIGH IMPACT FRAGRANCE SUBSTANCES SYMRISE AG (DE) 2025-04-09 EP disclosed
WO-2025045353-A1 A FRAGRANCE POD SYMRISE AG (DE) 2025-03-06 WO disclosed
EP-4516118-A2 USE OF AMBOCENIDE® FOR REINFORCING A LILY OF THE VALLEY NOTE Symrise AG (DE) 2025-03-05 EP disclosed
EP-3665163-B1 USE OF AMBROCENIDE® FOR ENHANCING THE FRAGRANCE OF LILLIES OF THE VALLEY SYMRISE AG (DE) 2024-12-25 EP disclosed
EP-4428219-A2 COMPOSITION FOR ODOUR IMPROVEMENT Symrise AG (DE) 2024-09-11 EP disclosed
EP-4247791-A2 NEW COOLANTS, AND PREPARATIONS CONTAINING SAME Symrise AG (DE) 2023-09-27 EP disclosed
WO-2023143741-A1 NEW COOLANTS, AND PREPARATIONS CONTAINING SAME SYMRISE AG (DE) 2023-08-03 WO disclosed
EP-3002280-B1 CYCLIC TRIAZO AND DIAZO SODIUM CHANNEL BLOCKERS UNIV GREENWICH (GB) 2023-05-24 EP disclosed
CN-115594724-A Glucosamine derivatives for preventing or treating joint diseases 润佳(苏州)医药科技有限公司(CN) 2023-01-13 CN disclosed
WO-2022220725-A1 LPXH INHIBITORS AS ANTI-INFECTIVE AGENTS ZAMARATSKI EDOUARD (SE) 2022-10-20 WO disclosed
CN-111971290-B Glucosamine derivatives for preventing or treating joint diseases 润佳(苏州)医药科技有限公司 2022-10-14 CN disclosed
WO-2022105986-A1 NOVEL COOLING AGENTS AND PREPARATIONS CONTAINING SAME SYMRISE AG (DE) 2022-05-27 WO disclosed
WO-2022106452-A2 NEW COOLANTS, AND PREPARATIONS CONTAINING SAME SYMRISE AG (DE) 2022-05-27 WO disclosed
CN-114008025-A ACSS2 inhibitors and methods of use thereof 美特波米德有限公司 2022-02-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250170074-A1 PRECURSORS FOR THE CONTROLLED RELEASE OF A,B-UNSATURATED ALDEHYDES OR KETONES AND OTHER HIGH IMPACT FRAGRANCE SUBSTANCES FAAH2, TRPA1, FAAH SGMS2 443/4885FOLH1 1176/4885PTGER1 136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.